Literature DB >> 31047756

A Review of Chronic Leukoencephalopathy among Survivors of Childhood Cancer.

Sonia Partap1, Suzanne Russo2, Bijan Esfahani3, Kristen Yeom4, Claire Mazewski5, Leanne Embry6, Greg Wheeler7, Nicole J Ullrich8, Daniel C Bowers9.   

Abstract

Currently, there are an estimated 400,000 long-term survivors of childhood cancer in the United States. Chronic leukoencephalopathy is a potential devastating late effect that can manifest as a range of neurological and neurocognitive sequelae. Survivors of the acute lymphocytic leukemia, central nervous system tumors, and stem cell transplant have frequently been exposed to cranial radiation, systemic and intrathecal chemotherapy, which places them at risk of developing chronic leukoencephalopathy. Defining leukoencephalopathy and its neuroimaging characteristics, the population of survivors at risk, its long-term consequences, and identifying prevention and intervention strategies can potentially mitigate the morbidity of these survivors. Better understanding of those at risk of leukoencephalopathy and its symptoms can lead to an improved quality of life for these cancer survivors.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemotherapy; Childhood cancer; Chronic leukoencephalopathy; Radiation therapy; Stem cell transplant; Survivorship

Year:  2019        PMID: 31047756     DOI: 10.1016/j.pediatrneurol.2019.03.006

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  5 in total

1.  An Integrated Analysis of Clinical, Genomic, and Imaging Features Reveals Predictors of Neurocognitive Outcomes in a Longitudinal Cohort of Pediatric Cancer Survivors, Enriched with CNS Tumors (Rad ART Pro).

Authors:  Cassie Kline; Schuyler Stoller; Lennox Byer; David Samuel; Janine M Lupo; Melanie A Morrison; Andreas M Rauschecker; Pierre Nedelec; Walter Faig; Dena B Dubal; Heather J Fullerton; Sabine Mueller
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

Review 2.  Neurotoxic Effects of Childhood Cancer Therapy and Its Potential Neurocognitive Impact.

Authors:  Nicholas S Phillips; Elizabeth S Duke; Hannah-Lise T Schofield; Nicole J Ullrich
Journal:  J Clin Oncol       Date:  2021-04-22       Impact factor: 50.717

Review 3.  Brain Imaging in Pediatric Cancer Survivors: Correlates of Cognitive Impairment.

Authors:  Shelli R Kesler; Charlotte Sleurs; Brenna C McDonald; Sabine Deprez; Ellen van der Plas; Brian J Nieman
Journal:  J Clin Oncol       Date:  2021-04-22       Impact factor: 50.717

4.  Cystlike Lesions as a Late Sequela of Radiotherapy in Pediatric Patients.

Authors:  M G D Veiga; I Fragata; J Passos; M Alves; A L Papoila; D Salgado
Journal:  AJNR Am J Neuroradiol       Date:  2021-06-17       Impact factor: 4.966

5.  Child Neglect by Any Other Name.

Authors:  E Steve Roach
Journal:  Pediatr Neurol       Date:  2020-09-17       Impact factor: 3.372

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.